INDUSTRY
PROGRAMME
EULAR 2025 | INDUSTRY PROGRAMME
SATELLITE SYMPOSIA & CONSULT THE EXPERT
A number of Satellite Symposia and Consult the Expert sessions will be organised during EULAR 2025. We invite you to explore our Industry Programme e-booklet to discover which ones. Satellite Symposia and Consult the Expert sessions are governed by the EULAR Code of Practice, and are strictly prohibited during the official programme hours. All industry sessions and special events must be approved by EULAR.
In order to adhere to local and European regulations, primarily concerning prescription rights, participants with a white dot on their EULAR 2025 Congress badge are not permitted to access any industry sessions (Satellite Symposia or Consult the Expert). Exhibitor badges are only valid for entry to the sessions they are organising. Thank you for adhering to the rules.
SCHEDULE OVERVIEW
| WEDNESDAY, 11 JUNE 2025 | |
| 15:15 - 15:45 CEST | Consult the Expert (1 session) |
| 18:30 - 19:45 CEST | Satellite Symposia (8 sessions) |
THURSDAY, 12 JUNE 2025 | |
| 08:15 - 09:30 CEST | Satellite Symposia (8 sessions) |
| 09:45 - 10:15 CEST | Consult the Expert (3 sessions) |
| 15:00 - 15:30 CEST | Consult the Expert (3 sessions) |
| 17:30 - 18:45 CEST | Satellite Symposia (7 sessions) |
FRIDAY, 13 JUNE 2025 | |
| 08:15 - 09:30 CEST | Satellite Symposia (5 sessions) |
| 09:45 - 10:15 CEST | Consult the Expert (3 sessions) |
| 15:00 - 15:30 CEST | Consult the Expert (3 sessions) |
| 17:30 - 18:45 CEST | Satellite Symposia (2 sessions) |
SATELLITE SYMPOSIUM PROGRAMME OVERVIEW
11 June I 18:30 – 19:45 CEST
AbbVie - The JAK Inhibitor Connection: An Interactive, Practical Exchange to Bridge Specialties for Better Patient Outcomes – Today and Tomorrow
11 June I 18:30 – 19:45 CEST
Alfasigma - Raising the bar: how can early disease control with JAK inhibitors redefine long-term outcomes in RA?
11 June I 18:30 – 19:45 CEST
AstraZeneca - Transforming the SLE care paradigm: the urgency for a more proactive approach to target remission
11 June I 18:30 – 19:45 CEST
GSK - Advancing lupus care: preventing organ damage in SLE, preserving the kidney in LN
11 June I 18:30 – 19:45 CEST
Johnson & Johnson - One disease, countless stories: managing the complexities of psoriatic arthritis
11 June I 18:30 – 19:45 CEST
Medscape - Unmet Needs In B-Cell Mediated Autoimmune Diseases: What Can B-Cell Depletion Therapies Offer?
11 June I 18:30 – 19:45 CEST
MSD - Bridging the Gap: Multidisciplinary Insights into SSC-ILD Progression and Diagnosis
11 June I 18:30 – 19:45 CEST
UCB - Made for Her: Joints to Bones, from Inception to Legacy
CONSULT THE EXPERT PROGRAMME OVERVIEW
11 June I 15:45 – 16:15 CEST
UCB - Motherhood and Systemic Lupus Erythematosus: Navigating the Unknowns
12 June I 09:45 – 10:15 CEST
AbbVie - Your GCA Questions Answered – From Diagnosis to Long-term Care
12 June I 09:45 – 10:15 CEST
GSK - Act now: The case for early intervention and disease modification in SLE and LN
12 June I 09:45 – 10:15 CEST
UCB - Cracking the MRI Code in axSpA: How to Get the Right Images for the Right Diagnosis
12 June I 15:00 – 15:30 CEST
GSK - Looking ahead: Connecting the dots in CTD-ILD from immuno-pathophysiology to trial design
12 June I 15:00 – 15:30 CEST
Johnson & Johnson - Sharing is caring: practical insights into the challenges of psoriatic arthritis
12 June I 15:00 – 15:30 CEST
MSD - Systemic Lupus Erythematosus: Addressing Inflammation, Restoring Homeostasis, and Unveiling Unmet Needs
13 June I 09:45 – 10:15 CEST
AstraZeneca - Managing SLE across manifestations: expert perspectives on preventing organ damage
13 June I 09:45 – 10:15 CEST
BMS - Exploring Sex Differences in Psoriatic Arthritis: Latest Insights and Practical Cases
13 June I 09:45 – 10:15 CEST
Eli Lilly - Pso2PsA: Where are we right now and where should we go?
13 June I 15:00 – 15:30 CEST
Alexion - Could It Be Hypophosphatasia (HPP)? A Conversation With Experts
13 June I 15:00 – 15:30 CEST
CSL Vifor - Bridging the gaps in ANCA-associated vasculitis care: Expert insights and patient perspectives
13 June I 15:00 – 15:30 CEST
GSK - Advancing EGPA care: The evolving IL-5 science
13 June I 09:45 – 10:15 CEST
AstraZeneca - Managing SLE across manifestations: expert perspectives on preventing organ damage
Session details
13 June I 09:45 – 10:15 CEST
BMS - Exploring Sex Differences in Psoriatic Arthritis: Latest Insights and Practical Cases
Session details
13 June I 09:45 – 10:15 CEST
Eli Lilly - Pso2PsA: Where are we right now and where should we go?
Session details
13 June I 15:00 – 15:30 CEST
Alexion - Could It Be Hypophosphatasia (HPP)? A Conversation With Experts
Session details
13 June I 15:00 – 15:30 CEST
CSL Vifor - Bridging the gaps in ANCA-associated vasculitis care: Expert insights and patient perspectives
Session details
13 June I 15:00 – 15:30 CEST
GSK - Advancing EGPA care: The evolving IL-5 science
Session details
12 June I 08:15 – 09:30 CEST
Amgen - MITIGATing the Impact of IgG4-RD: Unmet Needs and Emerging Data
12 June I 08:15 – 09:30 CEST
AstraZeneca - Reducing steroids and achieving remission in EGPA
12 June I 08:15 – 09:30 CEST
BMS - CAR T Cell Therapy: Potential for Immune Reset in Autoimmune Diseases
12 June I 08:15 – 09:30 CEST
Boehringer Ingelheim - State of the art in the management of systemic sclerosis
12 June I 08:15 – 09:30 CEST
Eli Lilly - Unravelling the complexity of Inflammation in rheumatic diseases, a deep dive into CRP
12 June I 08:15 – 09:30 CEST
Merck - Toll-like receptors: Unlocking new frontiers in lupus
12 June I 08:15 – 09:30 CEST
Novartis - Hidden Depths: Diving beneath the surface knowledge of IL-17A in SpA
12 June I 08:15 – 09:30 CEST
Otsuka - Multi-target treatments and a multidisciplinary approach: How they can improve care for patients with Lupus Nephritis
12 June I 17:30 – 18:45 CEST
AbbVie - Closing the Loop: Bridging the Gap from Clinical Trials to Real-World Evidence
12 June I 17:30 – 18:45 CEST
AstraZeneca - From remission to organ damage prevention: acting early in SLE
12 June I 17:30 – 18:45 CEST
BMS - TYK-ing the Path Forward in PsA
12 June I 17:30 – 18:45 CEST
CSL Vifor - Mapping a path forward: Addressing disease burden, pathways and solutions in ANCA-associated vasculitis
12 June I 17:30 – 18:45 CEST
Johnson & Johnson - All roads lead here: a GUIDE to DISCOVERing the GALAXI
12 June I 17:30 – 18:45 CEST
Roche - Advances in lupus nephritis: what’s next?
12 June I 17:30 – 18:45 CEST
UCB - Leave your Footprint in SpAce: Embark on a Mission to Remission
CONSULT THE EXPERT PROGRAMME OVERVIEW
11 June I 15:45 – 16:15 CEST
UCB - Motherhood and Systemic Lupus Erythematosus: Navigating the Unknowns
12 June I 09:45 – 10:15 CEST
AbbVie - Your GCA Questions Answered – From Diagnosis to Long-term Care
12 June I 09:45 – 10:15 CEST
GSK - Act now: The case for early intervention and disease modification in SLE and LN
12 June I 09:45 – 10:15 CEST
UCB - Cracking the MRI Code in axSpA: How to Get the Right Images for the Right Diagnosis
12 June I 15:00 – 15:30 CEST
GSK - Looking ahead: Connecting the dots in CTD-ILD from immuno-pathophysiology to trial design
12 June I 15:00 – 15:30 CEST
Johnson & Johnson - Sharing is caring: practical insights into the challenges of psoriatic arthritis
12 June I 15:00 – 15:30 CEST
MSD - Systemic Lupus Erythematosus: Addressing Inflammation, Restoring Homeostasis, and Unveiling Unmet Needs
13 June I 09:45 – 10:15 CEST
AstraZeneca - Managing SLE across manifestations: expert perspectives on preventing organ damage
13 June I 09:45 – 10:15 CEST
BMS - Exploring Sex Differences in Psoriatic Arthritis: Latest Insights and Practical Cases
13 June I 09:45 – 10:15 CEST
Eli Lilly - Pso2PsA: Where are we right now and where should we go?
13 June I 15:00 – 15:30 CEST
Alexion - Could It Be Hypophosphatasia (HPP)? A Conversation With Experts
13 June I 15:00 – 15:30 CEST
CSL Vifor - Bridging the gaps in ANCA-associated vasculitis care: Expert insights and patient perspectives
13 June I 15:00 – 15:30 CEST
GSK - Advancing EGPA care: The evolving IL-5 science
13 June I 08:15 – 09:30 CEST
Amgen - DAZzling beyond B cells: Addressing the heterogeneity of Sjögren’s disease
13 June I 08:15 – 09:30 CEST
Boehringer Ingelheim - Perfect Partnerships in Fibrosing Connective Tissue Disease (CTD)-Associated ILDs
13 June I 08:15 – 09:30 CEST
GSK - Evolving Expectations in EGPA: Striving for Remission with RWE
13 June I 08:15 – 09:30 CEST
Medac - Current trends of methotrexate therapy – do you know it all?
13 June I 08:15 – 09:30 CEST
UCB & Biogen - Shifting the Paradigm Beyond B Cells: Targeting Upstream Immune Drivers in Systemic Lupus Erythematosus
13 June I 17:30 – 18:45 CEST
Sanofi - The Clock is Ticking: When to Break Free from Glucocorticoids in Polymyalgia Rheumatica?
13 June I 17:30 – 18:45 CEST
Sobi - Putting on your VEXAS goggles: Seeing what’s in plain sight
CONSULT THE EXPERT PROGRAMME OVERVIEW
11 June I 15:45 – 16:15 CEST
UCB - Motherhood and Systemic Lupus Erythematosus: Navigating the Unknowns
12 June I 09:45 – 10:15 CEST
AbbVie - Your GCA Questions Answered – From Diagnosis to Long-term Care
12 June I 09:45 – 10:15 CEST
GSK - Act now: The case for early intervention and disease modification in SLE and LN
12 June I 09:45 – 10:15 CEST
UCB - Cracking the MRI Code in axSpA: How to Get the Right Images for the Right Diagnosis
12 June I 15:00 – 15:30 CEST
GSK - Looking ahead: Connecting the dots in CTD-ILD from immuno-pathophysiology to trial design
12 June I 15:00 – 15:30 CEST
Johnson & Johnson - Sharing is caring: practical insights into the challenges of psoriatic arthritis
12 June I 15:00 – 15:30 CEST
MSD - Systemic Lupus Erythematosus: Addressing Inflammation, Restoring Homeostasis, and Unveiling Unmet Needs
13 June I 09:45 – 10:15 CEST
AstraZeneca - Managing SLE across manifestations: expert perspectives on preventing organ damage
13 June I 09:45 – 10:15 CEST
BMS - Exploring Sex Differences in Psoriatic Arthritis: Latest Insights and Practical Cases
13 June I 09:45 – 10:15 CEST
Eli Lilly - Pso2PsA: Where are we right now and where should we go?
13 June I 15:00 – 15:30 CEST
Alexion - Could It Be Hypophosphatasia (HPP)? A Conversation With Experts
13 June I 15:00 – 15:30 CEST
CSL Vifor - Bridging the gaps in ANCA-associated vasculitis care: Expert insights and patient perspectives
13 June I 15:00 – 15:30 CEST
GSK - Advancing EGPA care: The evolving IL-5 science
Not yet available.